After sudden construction, Spark Biotech Company finally built a factory.

On December 2, Zhou Yu visited the factory not far from the company's headquarters.

Wang Jian led Zhou Yu to visit the factory and introduced the latest product situation.

"Director Wang Xiaoxiao led the scientific researchers of the Institute of Life Sciences to cooperate with major medical institutions in Yanjing to conduct clinical experiments on three products.

After the documentary advertisement was broadcast, many critically ill patients applied for clinical experiments.

Their addition has improved the data on many diseases, making the clinical experiment progress very quickly, and the competent authorities have also sent experts to keep an eye on the data on clinical experiments.

Because of the great pressure in society, many well-known people and veteran cadres wrote letters to the competent departments, asking them to quickly review cell missiles and other products.

After the competent department determines the safety and true effect of our products, the drugs that have been approved by us have been reviewed and approved, and the drug number has been issued and can be officially launched on the market."

"Things are going well. Let's first look at the situation in the factory. The normal production of drugs is sufficient, and then it will be launched.

I have ordered Xinghuo Intelligent Company that they have trained the AI ​​masters and will have the AI ​​masters to guide the doctors to take medicine." Zhou Yu said happily.

He knew that after these three drugs were launched, they would definitely be targeted by domestic and foreign pharmaceutical groups, but these three drugs were all drugs that benefit the country and the people.

According to experts' estimates, they can increase the average life expectancy in China by at least 5 years, reducing the death rate of children under ten years old by 95%.

At the same time, it also surpasses artificial intelligence and software games and becomes the most profitable project of Spark Technology.

For the sake of profit and reputation, Spark Technology is not afraid of any challenges now.

As long as you don’t have the ability to erase Spark Technology from the earth, trade wars and other battles, the size of Spark Technology is now without fear.

Wang Jian took Zhou Yu into the factory, and there were huge glass jars in it.

The glass jar is strictly sealed, the product is completely kept in a sterile state, and the glass jar shows a holographic image, and there are numerous sensors to monitor every data of the product.

Zhou Yu had long been learning about the production process of the agent from Director Wang Xiaoxiao.

In addition to disease screening agents, the other two agents are inspiration obtained from studying hematopoietic stem cells.

The production of these three agents is also inseparable from cell culture technology. This is actually a veritable cell factory.

Zhou Yu and Wang Jian walked to the production workshop, where they were equipment composed of thousands of small jars, which were the production equipment for disease screening agents.

Zhou Yu immediately remembered the process of producing disease screening agents.

Disease screening agents are a complex group of peptide solutions, and more than 1,000 peptides are mixed together to form disease screening agents.

Each polypeptide can and can only react with a pheromone in human plasma. The result of the reaction is that the polypeptide chain folds to form a fluorescent protein.

As long as you test the type of fluorescent protein in the reagent, you can read out the disease that the sample provider suffers from.

Each peptide is expressed through modern gene technology, a small piece of gene fragment is transplanted into a yeast cell screened in the laboratory.

During the proliferation of yeast cells, a large amount of peptide substances will be produced.

When all the peptides are mixed together, they become disease screening agents.

Wang Jian introduced to Zhou Yu: "Disease screening agent is a polypeptide solvent. Its optimal storage temperature is around zero degrees. Once the temperature exceeds 40 degrees, the polypeptide chain will automatically dehydrate and condense, losing the effect of detecting diseases.

Each disease screening agent is made into a reagent bottle the size of a little finger and transported to a medical institution through special vehicles.

The instruments that use disease screening agents have been handed over to Xinghuo Precision Manufacturing Company for production, and they have a lot of orders."

Zhou Yu and Wang Jian walked to the production workshop on the left again. There were many glass jars containing red liquid and light yellow liquid. At first glance, they were the production equipment for blood cells and plasma.

The technology of plasma production is very simple, water accounts for about 92%, and most of it is plasma protein, which contains a small amount of nutrients, electrolytes, enzymes, hormones, etc.

As long as you master the optimal ratio, it is easy to synthesize plasma.

The real difficulty is the production of blood cells, especially platelets and red blood cells. They are functional cells that play a decisive role in the blood. The cells produced in industries must be made cellularly active.

Director Wang Xiaoxiao cultivated hematopoietic stem cells similar to cancer cells through genetic modification technology.

This genetically modified hematopoietic stem cell is completely different from cancer cells.

Cancer cells have infinite proliferation ability, but they have lost their ability to differentiate.

Genetically modified hematopoietic stem cells have the infinite proliferation ability of cancer cells, but they still maintain the ability to differentiate functional cells.

When hematopoietic stem cells are cultured in nutrients, they have infinite proliferation ability and can quickly reproduce themselves.

Once chemical reagents are used to induce, this hematopoietic stem cell will differentiate into corresponding blood cells, mainly red blood cells, white blood cells and platelets.

Wang Jian pointed to these tanks and introduced: "This is the artificial blood produced by our company. Now 10 tons of artificial blood can be produced every day.

We encapsulate various types of blood, and our company has its own transportation fleet, transporting finished blood through professional vehicles.

We also cooperate with the Railway Corporation to transport blood through the method of mounting special high-speed rail cars."

When Zhou Yu heard Wang Jian’s introduction, he was a little surprised. The way to cooperate with the Railway Corporation was completely negotiated by Wang Jian based on his own ability.

This method is really good. The fastest one is air transport, but the artificial blood transport requirements are high and the aircraft needs to be transformed, which makes the transportation cost too high.

The rest is the cost of transforming a car through high-speed rail transportation, which Xinghuo Biotech can afford, but the most important issue is to open up the railway company's channels.

"You did a great job in this. If it is really emergency blood, you can send someone to carry it on a small scale through air transport. The high-speed railway network is really a good choice." Zhou Yu praised.

They finally came to the production workshop of cell missiles, which were tall and giant cans.

Cell missile production technology is similar to hematopoietic stem cells. It first stimulates lymph B cells with antigens to allow them to produce plasma cells that can produce specific antibodies.

Then, through genetic modification technology, plasma cells have infinite proliferation ability, and at the same time, the ability to generate antibodies is changed by modifying genes.

In this way, the genetically modified plasma cells can be placed in the culture medium and they can continuously produce the same antibodies.

Wang Jian introduced: "Cell missiles are mature protein antibodies. They are very well adapted to ultra-low temperatures and can withstand high temperatures of about 50 degrees.

It only needs to change the packaging material and can be transported at room temperature."

Zhou Yu looked at the huge cell factory that was running independently without a single person.
Chapter completed!